
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.
Learn more
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.









